SAN DIEGO, Jan. 27, 2012 /PRNewswire/ -- Gen-Probe
Incorporated (NASDAQ: GPRO) announced today that the Company will
release its fourth quarter and full year 2011 financial results on
Monday, February 13, 2012, at
approximately 4:00 p.m. Eastern Time
(ET). The announcement will be followed by a conference call with
management at 4:30 p.m.
ET.
The conference call will be webcast live and may be
accessed on the investors section of the Company's web site at
www.gen-probe.com. An archived version of the webcast will be
available on the same web site for at least 90 days. A telephone
replay also will be available for 24 hours after the call ends. To
access the replay, please call 866-501-7043 (US) or 203-369-1846
(international).
About Gen-Probe
Gen-Probe Incorporated is a global leader in the
development, manufacture and marketing of rapid, accurate and
cost-effective molecular diagnostic products and services that are
used primarily to diagnose human diseases, screen donated human
blood, and ensure transplant compatibility. Gen-Probe has
nearly three decades of expertise in nucleic acid testing (NAT),
and received the 2004 National Medal of Technology, America's
highest honor for technological innovation, for developing NAT
assays for blood screening. Gen-Probe is headquartered in
San Diego and employs
approximately 1,400 people. For more information, go to
www.gen-probe.com.
Caution Regarding Forward-Looking
Statements
Any statements in this press release about our
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and are
forward-looking statements. Forward-looking statements are not
guarantees of performance. They involve known and unknown risks,
uncertainties and assumptions that may cause actual results to
differ materially from those expressed or implied. For
information about risks and uncertainties we face and a discussion
of our financial statements and footnotes, see documents we have
filed with the SEC, including our most recent Form 10-K, and all
subsequent periodic filings. We assume no obligation and expressly
disclaim any duty to update any forward-looking statement to
reflect events or circumstances after the date of this press
release or to reflect the occurrence of unanticipated
events.
SOURCE Gen-Probe Incorporated